Across TCGA pan-cancer cohorts, SPINK5 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SPINK5’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SPINK5 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SPINK5 is over-expressed in tumor, although a few such as HNSC and CCRCC show the opposite, repressed pattern.
HNSC, CCRCC, and LSCC are the cancer types where SPINK5 tumor–normal differential expression is most reproducible.